David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
TechTarget
TTGT
$276M
| $3.12M | ﹤0.01% |
109,684
-21,928
| -17% | -$525K |
|
1852
PUT
Boston Properties
BXP
$11.3B
| $3.11M | ﹤0.01% |
24,800
| – | – |
|
|
USCR
1853
PUT
DELISTED
U S Concrete, Inc.
USCR
| $3.1M | ﹤0.01% |
59,100
+54,800
| +1,274% | +$3.26M |
|
|
XENT
1854
DELISTED
Intersect ENT, Inc
XENT
| $3.1M | ﹤0.01% |
82,823
+52,763
| +176% | +$2.07M |
|
1855
CALL
Landstar System
LSTR
$6.13B
| $3.1M | ﹤0.01% |
28,400
-5,600
| -16% | -$615K |
|
1856
GrafTech
EAF
$183M
| $3.1M | ﹤0.01% |
+17,209
| New | +$3.14M |
|
1857
PUT
International Paper
IP
$22.1B
| $3.09M | ﹤0.01% |
+62,726
| New | +$3.2M |
|
1858
ScottsMiracle-Gro
SMG
$3.64B
| $3.09M | ﹤0.01% |
37,201
+33,049
| +796% | +$2.77M |
|
1859
Nomad Foods
NOMD
$1.67B
| $3.09M | ﹤0.01% |
160,981
+42,505
| +36% | +$736K |
|
1860
PUT
Spectrum Brands
SPB
$2.04B
| $3.08M | ﹤0.01% |
37,800
-1,900
| -5% | -$160K |
|
1861
ZTO Express
ZTO
$16.3B
| $3.08M | ﹤0.01% |
154,262
+103,176
| +202% | +$1.86M |
|
1862
PUT
Amgen
AMGN
$238B
| $3.08M | ﹤0.01% |
16,700
+3,300
| +25% | +$584K |
|
1863
argenx
ARGX
$65.6B
| $3.07M | ﹤0.01% |
+37,005
| New | +$3.31M |
|
|
AVNS
1864
DELISTED
Avanos Medical
AVNS
| $3.06M | ﹤0.01% |
53,531
+44,881
| +519% | +$2.37M |
|
1865
Altisource Portfolio Solutions
ASPS
$66.7M
| $3.06M | ﹤0.01% |
13,107
-1,240
| -9% | -$283K |
|
1866
CALL
Stellantis
STLA
$19.6B
| $3.05M | ﹤0.01% |
161,600
+42,000
| +35% | +$920K |
|
|
ACRE
1867
Ares Commercial Real Estate
ACRE
$260M
| $3.05M | ﹤0.01% |
220,885
+18,657
| +9% | +$247K |
|
1868
PUT
Check Point Software Technologies
CHKP
$13.1B
| $3.05M | ﹤0.01% |
+31,200
| New | +$3.09M |
|
1869
PUT
Everest Group
EG
$14.6B
| $3.04M | ﹤0.01% |
+13,200
| New | +$3.1M |
|
|
BOLD
1870
DELISTED
Audentes Therapeutics, Inc
BOLD
| $3.04M | ﹤0.01% |
79,531
+40,194
| +102% | +$1.49M |
|
1871
PUT
Casey's General Stores
CASY
$30.5B
| $3.04M | ﹤0.01% |
28,900
+21,500
| +291% | +$2.17M |
|
1872
CALL
Idexx Laboratories
IDXX
$43.5B
| $3.03M | ﹤0.01% |
+13,900
| New | +$2.86M |
|
1873
PUT
Royal Caribbean
RCL
$78B
| $3.02M | ﹤0.01% |
+29,200
| New | +$3.21M |
|
1874
PUT
Ventas
VTR
$48.2B
| $3.01M | ﹤0.01% |
52,800
-1,200
| -2% | -$62.8K |
|
1875
Terreno Realty
TRNO
$7.45B
| $3.01M | ﹤0.01% |
+79,808
| New | +$2.94M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.